SCHEMBL16488181

SCHEMBL16488181

CCCNC(=O)C1OC1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.42
CHRNB4 P30926 1/20 0.42
CHRNA3 P32297 1/20 0.42
CHRNA7 P36544 1/20 0.42
CHRNA4 P43681 1/20 0.42
BCHE P06276 1/20 0.41
MMP1 P03956 1/20 0.39
MMP2 P08253 1/20 0.39
MMP3 P08254 1/20 0.39
MMP9 P14780 1/20 0.39
EPHX1 P07099 2/20 0.38
MCL1 Q07820 1/20 0.36
GRM4 Q14833 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HSP90AA1 P07900 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
HSP90B1 P14625 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA2B P29275 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4902697 0.79 SUCNR1 (0.48) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL1121704 0.79 SUCNR1 (0.48) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL14638990 0.76 CHRNB2 (0.38) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL14067709 0.74 CAPN1 (0.51) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL11171419 0.74 CAPN1 (0.51) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL19975293 0.71 TDP1 (0.47) MMP1MMP2MMP3MMP9EPHX1
SCHEMBL10770501 0.71 TET2 (0.45) KDM4EALDH1A1EPHX2POLB
SCHEMBL19975131 0.71 TET2 (0.45) KDM4EALDH1A1EPHX2POLB
SCHEMBL22783656 0.70 CHRNB2 (0.36) CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4
SCHEMBL2502163 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2837629-B1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE ASYMCHEM LABORATORIES (TIANJIN) CO LTD (CN) 2017-03-22 EP disclosed
US-9371326-B2 Method for synthesizing sapropterin dihydrochloride ASYMCHEM LABORATORIES (TIANJIN) CO., LTD (CN) 2016-06-21 US disclosed
US-20150119573-A1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE TIANJIN ASYMCHEM PHARMACEUTICAL CO., LTD (CN) 2015-04-30 US disclosed
EP-2837629-A1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE Asymchem Laboratories (Tianjin) Co., Ltd (CN) 2015-02-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150119573-A1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE DHCR7, CYP51A1, HMGCR CHRNB2 1846/4885CHRNB4 1219/4885CHRNA3 1464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.